Search Results - "COOKE, J. P"

Refine Results
  1. 1

    Endogenous nitric oxide synthase inhibitor : A novel marker of atherosclerosis by MIYAZAKI, H, MATSUOKA, H, COOKE, J. P, USUI, M, UEDA, S, OKUDA, S, IMAIZUMI, T

    Published in Circulation (New York, N.Y.) (09-03-1999)
    “…Exposure to risk factors such as hypertension or hypercholesterolemia decreases the bioavailability of endothelium-derived nitric oxide (NO) and impairs…”
    Get full text
    Journal Article
  2. 2

    Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes by Asagami, T., Abbasi, F., Stuelinger, M., Lamendola, C., McLaughlin, T., Cooke, J.P., Reaven, G.M., Tsao, P.S.

    Published in Metabolism, clinical and experimental (01-07-2002)
    “…This study was initiated to see if plasma asymmetric dimethylarginine (ADMA) concentrations decreased in hyperglycemic patients with type 2 diabetes following…”
    Get full text
    Journal Article
  3. 3

    Novel mechanism for endothelial dysfunction dysregulation of dimethylarginine dimethylaminohydrolase by ITO, A, TSAO, P. S, ADIMOOLAM, S, KIMOTO, M, OGAWA, T, COOKE, J. P

    Published in Circulation (New York, N.Y.) (22-06-1999)
    “…Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS). Plasma levels of ADMA are elevated in individuals with…”
    Get full text
    Journal Article
  4. 4

    Asymmetric dimethylarginine (ADMA) : A novel risk factor for endothelial dysfunction : Its role in hypercholesterolemia by BÖGER, R. H, BODE-BÖGER, S. M, SZUBA, A, TSAO, P. S, CHAN, J. R, TANGPHAO, O, BLASCHKE, T. F, COOKE, J. P

    Published in Circulation (New York, N.Y.) (03-11-1998)
    “…Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthase. Because endothelial NO elaboration is impaired in…”
    Get full text
    Journal Article
  5. 5

    Phytoestrogens and cardiovascular health by Wroblewski Lissin, Lynette, Cooke, John P

    “…Coronary artery disease is the leading overall cause of mortality for women and increases dramatically after menopause. Estrogen has many beneficial…”
    Get full text
    Journal Article
  6. 6

    Gene Therapy Inhibiting Neointimal Vascular Lesion: In vivo Transfer of Endothelial Cell Nitric Oxide Synthase Gene by von der Leyen, Heiko E., Gibbons, Gary H., Morishita, Ryuichi, Lewis, Neil P., Zhang, Lunan, Nakajima, Masatoshi, Kaneda, Yasufumi, Cooke, John P., Dzau, Victor J.

    “…It is postulated that vascular disease involves a disturbance in the homeostatic balance of factors regulating vascular tone and structure. Recent developments…”
    Get full text
    Journal Article
  7. 7

    Cardiovascular Effects of Exercise: Role of Endothelial Shear Stress by Niebauer, Josef, Cooke, John P.

    “…Experimental, epidemiologic and clinical studies have provided strong evidence that physical exercise has beneficial effects on multiple physiological…”
    Get full text
    Journal Article
  8. 8

    NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease by Cooke, MD, John P, Dzau, MD, Victor J

    Published in Annual review of medicine (01-01-1997)
    “…The product of nitric oxide (NO) synthase is the most potent endogenous vasodilator known. NO not only is a potent vasodilator, it also inhibits platelet…”
    Get full text
    Journal Article
  9. 9

    Nitric Oxide Induces the Synthesis of Vascular Endothelial Growth Factor by Rat Vascular Smooth Muscle Cells by Dulak, Józef, Józkowicz, Alicja, Dembinska-Kiec, Aldona, Guevara, Ibeth, Zdzienicka, Anna, Zmudzinska-Grochot, Danuta, Florek, Izabela, Wójtowicz, Anna, Szuba, Andrzej, Cooke, John P

    “…ABSTRACTVascular endothelial growth factor (VEGF) is known to induce the release of nitric oxide (NO) from endothelial cells. However, the effect of NO on VEGF…”
    Get full text
    Journal Article
  10. 10

    Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit by COOKE, J. P, SINGER, A. H, TSAO, P, ZERA, P, ROWAN, R. A, BILLINGHAM, M. E

    Published in The Journal of clinical investigation (01-09-1992)
    “…The purpose of this study was to determine if chronic administration of L-arginine, the precursor of endothelium-derived relaxing factor (EDRF), normalizes…”
    Get full text
    Journal Article
  11. 11

    Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine by TSAO, P. S, MCEVOY, L. M, DREXLER, H, BUTCHER, E. C, COOKE, J. P

    Published in Circulation (New York, N.Y.) (01-05-1994)
    “…We have shown that chronic administration of the nitric oxide (NO) precursor L-arginine normalizes NO-dependent vasodilation and markedly inhibits…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Fatal herpes simplex virus hepatitis following neoadjuvant chemoradiotherapy and anterior resection for rectal cancer by Toomey, D P, Dhadda, A S, Sanni, L A, Cooke, J P, Hartley, J E

    “…We describe the case of a young patient who contracted fatal herpes simplex virus hepatitis following neoadjuvant chemoradiotherapy and anterior resection for…”
    Get full text
    Journal Article
  14. 14

    Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans by CREAGER, M. A, COOKE, J. P, MENDELSOHN, M. E, GALLAGHER, S. J, COLEMAN, S. M, LOSCALZO, J, DZAU, V. J

    Published in The Journal of clinical investigation (01-07-1990)
    “…The effect of hypercholesterolemia on vascular function was studied in humans. To eliminate the potential confounding effects of atherosclerosis, vascular…”
    Get full text
    Journal Article
  15. 15

    Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator by COOKE, J. P, ROSSITCH, E. JR, ANDON, N. A, LOSCALZO, J, DZAU, V. J

    Published in The Journal of clinical investigation (01-11-1991)
    “…Flow-mediated vasodilation is endothelium dependent. We hypothesized that flow activates a potassium channel on the endothelium, and that activation of this…”
    Get full text
    Journal Article
  16. 16

    Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes by Beisswenger, P. J., Brown, W. V., Ceriello, A., Le, N. A., Goldberg, R. B., Cooke, J. P., Robbins, D. C., Sarwat, S., Yuan, H., Jones, C. A., Tan, M. H.

    Published in Diabetic medicine (01-09-2011)
    “…Diabet. Med. 28, 1088–1095 (2011) Aim  To determine if a regimen with prandial + basal insulin compared with basal insulin attenuates post‐meal inflammatory…”
    Get full text
    Journal Article
  17. 17

    Shear stress elevates endothelial cGMP : role of a potassium channel and G protein coupling by OHNO, M, GIBBONS, G. H, DZAU, V. J, COOKE, J. P

    Published in Circulation (New York, N.Y.) (01-07-1993)
    “…The endothelium acts as the sensor of shear stress and as the mediator of flow-induced changes in vessel tone and structure. The purpose of this study was to…”
    Get full text
    Journal Article
  18. 18

    Fluid flow inhibits endothelial adhesiveness : Nitric oxide and transcriptional regulation of VCAM-1 by TSAO, P. S, BUITRAGO, R, CHAN, J. R, COOKE, J. P

    Published in Circulation (New York, N.Y.) (01-10-1996)
    “…In the arterial tree, regions exposed to reduced shear stress (low and/or disturbed flow) are predisposed to atherogenesis. Fluid flow is a potent stimulus for…”
    Get full text
    Journal Article
  19. 19
  20. 20

    History of oceanic front development in the New Zealand sector of the Southern Ocean during the Cenozoic-a synthesis by Nelson, Campbell S., Cooke, Penelope J.

    “…The New Zealand sector of the Southern Ocean (NZSSO) has opened about the Indian-Pacific spreading ridge throughout the Cenozoic. Today the NZSSO is…”
    Get full text
    Journal Article